An Intranasal Vaccine Based on Outer Membrane Vesicles Against SARS-CoV-2

The prevailing pandemic of SARS-CoV-2 highlights the desperate need of alternative vaccine-platforms, which are safe, effective, and can be modified to carry antigens of emerging pathogens. The current SARS-CoV-2 vaccines based on mRNA and adenoviral vector technology meet some of these criteria but...

Descripción completa

Detalles Bibliográficos
Autores principales: Thapa, Himadri B., Müller, Anna M., Camilli, Andrew, Schild, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602898/
https://www.ncbi.nlm.nih.gov/pubmed/34803974
http://dx.doi.org/10.3389/fmicb.2021.752739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602898/
https://www.ncbi.nlm.nih.gov/pubmed/34803974
http://dx.doi.org/10.3389/fmicb.2021.752739

Ejemplares similares